"These findings highlight the need to identify biological mechanisms contributing to sex specificity to facilitate risk stratification, targeted drug development, and improved management of long COVID," wrote the study's authors.
“Tranexamic acid significantly reduced the risk of perioperative bleeding without increasing cardiovascular risk in patients undergoing general surgery procedures,” said Lily J. Park, MD, MSc, and colleagues.
TAHO Pharmaceuticals completes pivotal trial of the first oral dissolving film anticoagulant, potentially transforming how life-saving therapies are delivered.